Contact
Email: | |
---|---|
Research group: | Molecular Oncology - Solid Cancer - Ondřej Slabý |
Workplace: |
Masarykova univerzita - CEITEC Masarykova Univerzita
|
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2021
- Burkon, P; Selingerova, I; Slavik, M; Pospisil, P; Bobek, L; Kominek, L; Osmera, P; Prochazka, T; Vrzal, M; Kazda, T; Slampa, P, 2021: Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients. FRONTIERS IN ONCOLOGY 10, doi: 10.3389/fonc.2020.616494
2020
- Belanova, R; Sprlakova-Pukova, A; Standara, M; Janu, E; Koukalova, R; Kristek, J; Burkon, P; Kolouskova, I; Prochazka, T; Pospisil, P; Chakravarti, A; Slampa, P; Slaby, O; Kazda, T, 2020: In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region. BIOMEDICAL PAPERS-OLOMOUC 164(3), p. 307 - 313, doi: 10.5507/bp.2019.039
- Gurin, D; Slavik, M; Hermanova, M; Selingerova, I; Kazda, T; Hendrych, M; Shatokhina, T; Vesela, M, 2020: The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma. JOURNAL OF ORAL PATHOLOGY & MEDICINE 49(9), p. 886 - 896, doi: 10.1111/jop.13055
- Lakomy, R; Kazda, T; Selingerova, I; Poprach, A; Pospisil, P; Belanova, R; Fadrus, P; Smrcka, M; Vybihal, V; Jancalek, R; Kiss, I; Muckova, K; Hendrych, M; Knight, A; Sana, J; Slampa, P; Slaby, O, 2020: Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable. DIAGNOSTICS 10(9), doi: 10.3390/diagnostics10090676
2019
- Kopkova, A; Sana, J; Machackova, T; Vecera, M; Radova, L; Trachtova, K; Vybihal, V; Smrcka, M; Kazda, T; Slaby, O; Fadrus, P, 2019: Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors. CANCERS 11(10), doi: 10.3390/cancers11101546
- Ahmad, P; Sana, J; Slavik, M; Gurin, D; Radova, L; Gablo, NA; Kazda, T; Smilek, P; Horakova, Z; Gal, B; Hermanova, M; Slampa, P; Slaby, O, 2019: MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy. CANCER GENOMICS & PROTEOMICS 16(2), p. 139 - 146, doi: 10.21873/cgp.20119
- Burkon, P; Kazda, T; Pospisil, P; Slavik, M; Kominek, L; Selingerova, I; Blakaj, DM; Prochazka, T; Vrzal, M; Rehak, Z; Slampa, P, 2019: Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study. NEOPLASMA 66(2), p. 315 - 325, doi: 10.4149/neo_2018_180731N558
2018
- Kazda, T; Dziacky, A; Burkon, P; Pospisil, P; Slavik, M; Rehak, Z; Jancalek, R; Slampa, P; Slaby, O; Lakomy, R, 2018: Radiotherapy of glioblastoma 15 years after the landmark Stupp´s trial: more controversies than standards?. RADIOLOGY AND ONCOLOGY 52(2), p. 121 - 128, doi: 10.2478/raon-2018-0023
- Kazda, T; Misove, A; Burkon, P; Pospisil, P; Hynkova, L; Selingerova, I; Dziacky, A; Belanova, R; Bulik, M; Rehak, Z; Poprach, A; Slama, O; Slampa, P; Slaby, O; Jancalek, R; Lakomy, R, 2018: Incidence of Hippocampal Metastases: Laterality and Implications for Unilateral Hippocampal Avoiding Whole Brain Radiotherapy. BIOMED RESEARCH INTERNATIONAL , doi: 10.1155/2018/2459608
- Gurin, D; Slavik, M; Hermanova, M; Shatokhina, T; Sana, J; Kazda, T; Selingerova, I; Ahmad, P; Smilek, P; Horakova, Z; Hendrych, M; Slampa, P; Slaby, O, 2018: Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. JOURNAL OF ORAL PATHOLOGY & MEDICINE 47(9), p. 864 - 872, doi: 10.1111/jop.12772
- Petrakova, K; Vyskocil, J; Grell, P; Majek, O; Soumarova, R; Novak, J; Burkon, P; Kral, Z; Kazda, T; Vyzula, R, 2018: Second cancers in Hodgkin´s lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 72(9), doi: 10.1111/ijcp.13235
- Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
- Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
- Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
- Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013